Literature DB >> 20713650

Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia.

Zélie Julia1, Emilie Duchene, Natalie Fournier, Natacha Bellanger, M John Chapman, Wilfried Le Goff, Maryse Guerin.   

Abstract

Lipid and cholesterol metabolism in the postprandial phase is associated with both quantitative and qualitative remodeling of HDL particle subspecies that may influence their anti-atherogenic functions in the reverse cholesterol transport pathway. We evaluated the capacity of whole plasma or isolated HDL particles to mediate cellular free cholesterol (FC) efflux, cholesteryl ester transfer protein (CETP)-mediated cholesteryl ester (CE) transfer, and selective hepatic CE uptake during the postprandial phase in subjects displaying type IIB hyperlipidemia (n = 16). Postprandial, large HDL2 displayed an enhanced capacity to mediate FC efflux via both scavenger receptor class B type I (SR-BI)-dependent (+12%; P < 0.02) and ATP binding cassette transporter G1 (ABCG1)-dependent (+31%; P < 0.008) pathways in in vitro cell systems. In addition, the capacity of whole postprandial plasma (4 h and 8 h postprandially) to mediate cellular FC efflux via the ABCA1-dependent pathway was significantly increased (+19%; P < 0.0003). Concomitantly, postprandial lipemia was associated with elevated endogenous CE transfer rates from HDL2 to apoB lipoproteins and with attenuated capacity (-17%; P < 0.02) of total HDL to deliver CE to hepatic cells. Postprandial lipemia enhanced SR-BI and ABCG1-dependent efflux to large HDL2 particles. However, postprandial lipemia is equally associated with deleterious features by enhancing formation of CE-enriched, triglyceride-rich lipoprotein particles through the action of CETP and by reducing the direct return of HDL-CE to the liver.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713650      PMCID: PMC2952576          DOI: 10.1194/jlr.P009746

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  42 in total

Review 1.  Methodology for studying postprandial lipid metabolism.

Authors:  D Lairon; J Lopez-Miranda; C Williams
Journal:  Eur J Clin Nutr       Date:  2007-04-25       Impact factor: 4.016

2.  Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid.

Authors:  B Jian; M de la Llera-Moya; L Royer; G Rothblat; O Francone; J B Swaney
Journal:  J Lipid Res       Date:  1997-04       Impact factor: 5.922

3.  The roles of different pathways in the release of cholesterol from macrophages.

Authors:  Maria Pia Adorni; Francesca Zimetti; Jeffrey T Billheimer; Nan Wang; Daniel J Rader; Michael C Phillips; George H Rothblat
Journal:  J Lipid Res       Date:  2007-08-29       Impact factor: 5.922

4.  Inhibition of CETP by torcetrapib attenuates the atherogenicity of postprandial TG-rich lipoproteins in type IIB hyperlipidemia.

Authors:  Maryse Guerin; Wilfried Le Goff; Emilie Duchene; Zélie Julia; Tu Nguyen; Tom Thuren; Charles L Shear; M John Chapman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-19       Impact factor: 8.311

5.  Postprandial lipemia is modified by the presence of the polymorphism present in the exon 1 variant at the SR-BI gene locus.

Authors:  P Pérez-Martínez; J López-Miranda; J M Ordovás; C Bellido; C Marín; P Gómez; J A Paniagua; J A Moreno; F Fuentes; F Pérez-Jiménez
Journal:  J Mol Endocrinol       Date:  2004-02       Impact factor: 5.098

6.  Torcetrapib differentially modulates the biological activities of HDL2 and HDL3 particles in the reverse cholesterol transport pathway.

Authors:  Giovanna Catalano; Zélie Julia; Eric Frisdal; Benoit Vedie; Natalie Fournier; Wilfried Le Goff; M John Chapman; Maryse Guerin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-26       Impact factor: 8.311

Review 7.  Molecular processes that handle -- and mishandle -- dietary lipids.

Authors:  Kevin Jon Williams
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

8.  Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.

Authors:  Sandeep Bansal; Julie E Buring; Nader Rifai; Samia Mora; Frank M Sacks; Paul M Ridker
Journal:  JAMA       Date:  2007-07-18       Impact factor: 56.272

9.  Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects.

Authors:  Giovanna Catalano; Emilie Duchene; Zélie Julia; Wilfried Le Goff; Eric Bruckert; M John Chapman; Maryse Guerin
Journal:  J Lipid Res       Date:  2007-12-05       Impact factor: 5.922

10.  Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux.

Authors:  Sandhya Sankaranarayanan; John F Oram; Bela F Asztalos; Ashley M Vaughan; Sissel Lund-Katz; Maria Pia Adorni; Michael C Phillips; George H Rothblat
Journal:  J Lipid Res       Date:  2008-09-30       Impact factor: 5.922

View more
  9 in total

1.  Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes.

Authors:  Hussein N Yassine; Alexandra Belopolskaya; Christina Schall; Craig S Stump; Serrine S Lau; Peter D Reaven
Journal:  Metabolism       Date:  2014-03-05       Impact factor: 8.694

2.  Postprandial remodeling of high-density lipoprotein following high saturated fat and high carbohydrate meals.

Authors:  Michelle Averill; Katya B Rubinow; Kevin Cain; Jake Wimberger; Ilona Babenko; Jessica O Becker; Karen E Foster-Schubert; David E Cummings; Andrew N Hoofnagle; Tomas Vaisar
Journal:  J Clin Lipidol       Date:  2019-11-22       Impact factor: 4.766

3.  Differences and similarities of postprandial lipemia in rodents and humans.

Authors:  Natalia B Panzoldo; Aline Urban; Eliane S Parra; Rogério Oliveira; Vanessa S Zago; Lívia R da Silva; Eliana C de Faria
Journal:  Lipids Health Dis       Date:  2011-05-23       Impact factor: 3.876

4.  A reduction of CETP activity, not an increase, is associated with modestly impaired postprandial lipemia and increased HDL-cholesterol in adult asymptomatic women.

Authors:  Eliane S Parra; Aline Urban; Natalia B Panzoldo; Rui T Nakamura; Rogério Oliveira; Eliana C de Faria
Journal:  Lipids Health Dis       Date:  2011-05-24       Impact factor: 3.876

5.  Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes.

Authors:  Runlu Sun; Pu Fang; Jieyu Jiang; Canxia Huang; Junjie Wang; Qi Guo; Hongwei Li; Xiaoying Wu; Xiangkun Xie; Yuan Jiang; Qian Chen; Jinlan Bao; Jingfeng Wang; Hong Wang; Yuling Zhang
Journal:  Cardiovasc Drugs Ther       Date:  2021-03-19       Impact factor: 3.947

6.  Postprandial decrease in LDL-cholesterol in men with metabolic syndrome.

Authors:  Anna Skoczyńska; Barbara Turczyn; Anna Wojakowska; Bogusława Kreczyńska; Marta Skoczyńska; Kamila Wojtas
Journal:  Open Med (Wars)       Date:  2015-02-03

7.  High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacity Are Not Affected by Supervised Exercise but Are Associated with Baseline Interleukin-6 in Patients with Peripheral Artery Disease.

Authors:  Mazen S Albaghdadi; Zheng Wang; Ying Gao; R Kannan Mutharasan; John Wilkins
Journal:  Front Cardiovasc Med       Date:  2017-03-02

Review 8.  The Alcohol-High-Density Lipoprotein Athero-Protective Axis.

Authors:  Corina Rosales; Baiba K Gillard; Antonio M Gotto; Henry J Pownall
Journal:  Biomolecules       Date:  2020-07-01

9.  Acute coronary syndrome remodels the protein cargo and functions of high-density lipoprotein subfractions.

Authors:  Ying Tan; Ting Rong Liu; Shui Wang Hu; Di Tian; Chen Li; Jian Kai Zhong; Hai Ge Sun; Tian Tian Luo; Wen Yan Lai; Zhi-Gang Guo
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.